نتائج البحث

Interactions with DNA Models of the Oxaliplatin Analog (cis -1,3-DACH)PtCl 2   †.

• Authors : Barbanente, Alessandra¹ (AUTHOR); Papadia, Paride² (AUTHOR); Di Cosola, Anna Maria¹ (AUTHOR)

Subjects: *OXALIPLATIN; *LIGANDS (Chemistry); *DNA

• Source: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 13, p7392. 16p.

تفاصيل العنوان

Real-world efficacy and safety of capecitabine with oxaliplatin in patients with advanced adenocarcinoma of the ampulla of Vater.

• Authors : Lee, Seunghwan¹ (AUTHOR); Park, Se Jun^1,2 (AUTHOR); Shin, Kabsoo^1,2 (AUTHOR)

• Source: BMC Cancer. 5/23/2024, Vol. 24 Issue 1, p1-9. 9p.

تفاصيل العنوان

Role of miRNA-181a in the treatment of oxaliplatin-induced neuropathy with asprosin: An examination in mouse dorsal root ganglia.

• Authors : Adam, Muhammed¹; Bulut, Ferah¹; Dalkilic, Semih²

• Source: Annals of Medical of Research. May2024, Vol. 31 Issue 5, p416-419. 4p.

تفاصيل العنوان

The synergistic effect of oxaliplatin and punicalagin on colon cancer cells Caco-2 death.

• Authors : Alsufiani, Hadeil Muhanna^1,2

Subjects: *COLON cancer; *CANCER cells; *CELL death

• Source: Journal of Health Sciences (Qassim University). Mar/Apr2024, Vol. 18 Issue 2, p33-37. 5p.

تفاصيل العنوان

Dorsal root ganglion inflammation by oxaliplatin toxicity: DPEP1 as possible target for peripheral neuropathy prevention.

• Authors : Álvarez-Tosco K; Laboratorio de Biología del Desarrollo, UD de Bioquímica y Biología Molecular, Universidad de La Laguna, San Cristóbal de La Laguna, Spain.; Unidad de Investigación, Hospital Universitario Nuestra Señora de la Candelaria, Instituto de Investigación Sanitaria de Canarias (IISC), Santa Cruz de Tenerife, Spain.

Subjects: Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/toxicity ; Ganglia, Spinal*/Ganglia, Spinal*/Ganglia, Spinal*/metabolism ; Ganglia, Spinal*/Ganglia, Spinal*/Ganglia, Spinal*/drug effects

• Source: BMC neuroscience [BMC Neurosci] 2024 Sep 15; Vol. 25 (1), pp. 44. Date of Electronic Publication: 2024 Sep 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100966986 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2202

تفاصيل العنوان

Oxaliplatin activates P53/miR-34a/survivin axis in inhibiting the progression of gastric cancer cells.

• Authors : Guo Q; Department of Gastrointestinal Surgery, The First Affiliated Hospital of Baotou Medical College, Baotou, China.; Department of Gastrointestinal Surgery, Qi Lu Hospital of Shandong University, Jinan, China.

Subjects: Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/drug therapy ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/metabolism ; Stomach Neoplasms*/Stomach Neoplasms*/Stomach Neoplasms*/pathology

• Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2024 Sep; Vol. 12 (9), pp. e70004.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN:

تفاصيل العنوان

Puerarin alleviates oxaliplatin-induced neuropathic pain by promoting Nrf2/GPX4-mediated antioxidative response.

• Authors : Dai C; School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei, China.; Zhen F

Subjects: Oxaliplatin*/Oxaliplatin*/Oxaliplatin*/adverse effects ; Neuralgia*/Neuralgia*/Neuralgia*/drug therapy ; Neuralgia*/Neuralgia*/Neuralgia*/chemically induced

• Source: PloS one [PLoS One] 2024 Aug 14; Vol. 19 (8), pp. e0308872. Date of Electronic Publication: 2024 Aug 14 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

تفاصيل العنوان

Hsa_circ_0071589 aggravates stemness and oxaliplatin resistance in colorectal cancer through sponging miR-133b to upregulate SOX13 expression.

• Authors : Lv L; Department of Breast and Thyroid Surgery, Liuzhou People's Hospital, NO.8, Wenchang Road, Liuzhou, 545006, Guangxi, People's Republic of China.; Yi L

Subjects: Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/genetics ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/pathology ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/metabolism

• Source: Molecular and cellular biochemistry [Mol Cell Biochem] 2024 Aug; Vol. 479 (8), pp. 2055-2068. Date of Electronic Publication: 2023 Jul 31.Publisher: Springer Country of Publication: Netherlands NLM ID: 0364456 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

A novel oxaliplatin-resistant gene signatures predicting survival of patients in colorectal cancer.

• Authors : QIOU GU¹; CHUILIN LAI¹; XIAO GUAN¹

• Source: Biocell. 2024, Vol. 48 Issue 2, p253-269. 17p.

تفاصيل العنوان

A Phase III Study Evaluating Glofitamab in Combination With Gemcitabine + Oxaliplatin vs Rituximab in Combination With Gemcitabine + Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

• Source: A Phase III, Open-Label, Multicenter, Randomized Study Evaluating the Efficacy and Safety of Glofitamab in Combination With Gemcitabine Plus Oxaliplatin Versus Rituximab

تفاصيل العنوان